Karim Richard Masri, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Chronic Cannabis Use with Hyperemesis, Epigastric Pain and Conditioned Showering Behavior: A Case Series.
Journal of Gastroenterology and Hepatology Research
Date: 02 2012

Pentad’s Triad.
Kansas Journal of Medicine
Date: 05 2012

Validity and Reliability Problems with Patient Global as a Component of the ACR/EULAR Remission Criteria as Used in Clinical Practice.
Journal of Rheumatology
Date: 06 2012

IgG4-related systemic disease: an uncommon presentation for an uncommon disease
Rheumatology International
Date: 02 2013

Systemic Sclerosis: Dilated Capillary Loops, Finger
ACR Image Bank
Date: 07 2015
images.rheumatology.org/bp/#/search/detail/14840257

Office Orthopedics.
The Johns Hopkins Internal Medicine Board Review: Certification and Recertification
5th Edition
Date: 10 2015
www.elsevier.com/books/the-johns-hopkins-internal-medicine-board-review/ashar/978-0-323-37733-1

LEFLUNOMIDE CO-THERAPY WITH PEGLOTICASE IN UNCONTROLLED GOUT
Annals of the Rheumatic Diseases
Volume: 79:454
Date: 06 2020
ard.bmj.com/content/79/Suppl_1/454.3.citation-tools

The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review
Seminars in Arthritis and Rheumatism
51(2):347-352.
Date: 04 2021
www.sciencedirect.com/science/article/pii/S004901722100007X?via%3Dihub

Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response
Current Rheumatology Reports
24(1):12-19
Date: 01 2022
link.springer.com/article/10.1007/s11926-022-01055-9

Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
Rheumatology and Therapeutics
9(2):555-563
Date: 04 2022
link.springer.com/article/10.1007/s40744-021-00421-w